Market Analysis: Vaccine Delivery Devices Sector to Achieve US$ 10.25 Billion by 2032

The global Vaccine Delivery Device Market is anticipated to expand at a compound annual growth rate (CAGR) of 9.5% between 2022 and 2032, according to a recently released Fact.MR analysis. By the end of 2032, the market is projected to reach US$ 10.25 billion.

For example, the UK government used £1 million from the Medical Research Council's Global Challenges Research Fund to investigate the Zika virus's genesis and spread. Furthermore, because these devices are used to treat meningitis, hepatitis A and B, and influenza, there is a greater need for them, which is expected to support the market expansion during the forecast period.

Prospects further elevated during the COVID-19 pandemic, as it created an urgency for developed and efficient vaccination devices, thereby elevating the market size. In addition, the initiatives taken by various governments and non-government organizations are anticipated to boost the market significantly.

For Critical Insights on This Market, Request a Sample Report

https://www.factmr.com/connectus/sample?flag=Srep_id=178

The growing financial backing from the government and non-governmental organizations has resulted in a slew of new advances in the field, boosting the market's size. The UK government, for example, allocated £1 million from the Global Challenges Research Fund to the Medical Research Council to investigate Zika Virus transmission and source.

Furthermore, the number of diabetic patients worldwide is increasing. According to the World Health Organization, 422 million people globally are affected by the condition, which is expected to increase the market throughout the forecast period.

Why is APEJ Predicted to be the Fastest-Growing Region?

Contribution of Developing Nations to Increase Demand for Vaccine Delivery Devices

APEJ is projected to be the fastest-growing region owing to the increasing patient pool. The presence of developing nations such as; India and China is projected to further boost the market in the region.

Moreover, the unmet vaccine demand in the untapped regions is predicted to augment the industry in APEJ in the coming time. Also, the rising geriatric population in the region can notably boost the demand for vaccination, thereby bolstering the market in APEJ. The region is forecast to grow at a CAGR of 12% through 2032.

To learn more about Vaccine Delivery Device Market, you can get in touch with our Analyst at https://www.factmr.com/connectus/sample?flag=AErep_id=178

Key Segments Covered in the Vaccine Delivery Device Industry Survey

By Product Type

Syringes-based Vaccine Delivery Devices
Jet Injectors-based Vaccine Delivery Devices Market
Other Vaccine Delivery Device Products

By Route of Administration

Subcutaneous Vaccine Delivery Devices
Intramuscular Vaccine Delivery Devices
Intradermal Vaccine Delivery Devices
Other Vaccine Delivery Devices

Get Customization on this Report for Specific Research Solutions

https://www.factmr.com/connectus/sample?flag=RCrep_id=178

Competitive Landscape

The key players of the global vaccine delivery devices market adopt strategies such as; collaboration, partnership, and acquisitions.

In April 2020, Zealand Pharma acquired Valeritas Holdings, a U.S based medical company for a price of USD 23 Mn.
In November 2021, Gerresheimar entered into a partnership with Midas Pharma for a new auto injector. The partnership comprises of the development and marketing of new generation auto injector.
In August 2021, the Vaccine developer Serum Institute of India acquired a 50% stake in pharma packaging company Schott Kaisha for an amount that was not disclosed. Schott AG is a Germany-based player that manufactures vials, syringes, and cartridges.

Key players in the Vaccine Delivery Device Market

Becton Dickinson Company
PharmaJet Inc.
Valeritas Holdings Inc.
Vaxxas Pty. Ltd
Gerresheimer AG
Schott AG
Antares Pharma, Inc.
3M Company

Browse Full Report @ https://www.factmr.com/report/178/vaccine-delivery-devices-market

Key Takeaways from the Market Study

By product type, syringes are likely to be most lucrative, accumulating US$ 900 Mn in value
Sales of intramuscular vaccine delivery devices to reach a value of US$ 1 Bn by 2022
North America to be a potential revenue hub, forecast to incline at a 10% CAGR
APEJ to be the most opportunistic market, flourishing at 12% CAGR from 2022-2032
Global vaccine delivery devices market likely to be valued at over US$ 4 Bn by 2022-end